Skip to main content
FBRX logo

FBRX · Forte Biosciences, Inc.

$50.73 +3.24 (+6.82%) At close · Jul 21
Market Cap
$704.42M
Shares
13.89M

Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
94/100
Short interest 13.6% of shares — P94 Days to cover 3.5 — P66 Price vs VWAP +66.3% — P99 Short-volume trend +10.5% — P83 Short interest change +29.5% — P82 Worst FTD 0.06% of shares — P68 Volume surge +10

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-06-30 1,891,440 1,460,997 +430,443 3.48
2026-06-15 1,460,997 1,367,728 +93,269 5.08
2026-05-29 1,367,728 1,205,222 +162,506 6.10
2026-05-15 1,205,222 1,036,928 +168,294 5.71
2026-04-30 1,036,928 843,652 +193,276 4.43
2026-04-15 843,652 892,176 -48,524 1.49
2026-03-31 892,176 727,297 +164,879 3.51
2026-03-13 727,297 712,069 +15,228 3.85
2026-02-27 712,069 781,705 -69,636 4.56
2026-02-13 781,705 688,524 +93,181 3.24
2026-01-30 688,524 795,862 -107,338 2.83
2026-01-15 795,862 511,832 +284,030 3.94
2025-12-31 511,832 139,200 +372,632 2.35
2025-12-15 139,200 129,120 +10,080 1.56
2025-11-28 129,120 427,816 -298,696 1.00
2025-11-14 427,816 472,924 -45,108 6.79
2025-10-31 472,924 260,721 +212,203 4.25
2025-10-15 260,721 173,022 +87,699 3.14
2025-09-30 173,022 112,799 +60,223 1.46
2025-09-15 112,799 98,902 +13,897 1.72
2025-08-29 98,902 101,503 -2,601 1.13
2025-08-15 101,503 128,748 -27,245 1.51
2025-07-31 128,748 128,031 +717 3.60
Showing 1–23 of 23 settlements
Key facts CIK 1419041 CUSIP 34962G208 13F (30d) 3 filings 3 filers Visit website Investor relations